School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130024,China.
Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China.
Int J Biol Macromol. 2019 Feb 15;123:713-722. doi: 10.1016/j.ijbiomac.2018.11.140. Epub 2018 Nov 17.
The study aims to clarify the structural domain required for the immune enhancement of ginseng neutral polysaccharide (GPN). GPN was first obtained through water extraction and ion-exchange chromatography from Panax ginseng. GPN was hydrolyzed by α-amylase for 24 h and fractionated through gel permeation chromatography to give two final fragments GPNE-I and GPNE-II, with molecular weight of 8.03 × 10 Da for GPNE-I and 3.15 × 10 Da for respectively. FT-IR, methylation and 1D/2D NMR analysis demonstrated that GPNE-I was a heteropolysaccharide consisting mainly of a glucan domain and type I and II arabinogalactans (AG-I and AG-II). GPNE II was a glucan consisting of (1 → 4)-α-d-Glcp backbone with a substitution at O-6 on every two residues. (1 → 3)-α-d-Glcp and (1 → 6)-α-d-Glcp were located at the branches. In the two fractions, both α- and β-t-Glcp as reductive terminals and →4)-α-Glcp as a non-reducing end were detected. The branching degrees of GPNE-I and GPNE-II were 38.17% and 50.78%, respectively. Immunological experiments revealed that GPNE-I exhibited more effectively stimulated lymphocyte proliferation than GPN and GPNE-II, indicating the former showed potential for immunomodulators applications, indicating that GPNE-I might be the core active domain and necessary for GPN to promote lymphocyte proliferation.
本研究旨在阐明人参中性多糖(GPN)的免疫增强结构域。首先通过水提和离子交换层析从人参中获得 GPN。用α-淀粉酶水解 24 小时,然后通过凝胶渗透层析进行分级,得到两个最终片段 GPNE-I 和 GPNE-II,GPNE-I 的分子量为 8.03×10 Da,GPNE-II 的分子量为 3.15×10 Da。FT-IR、甲基化和 1D/2D NMR 分析表明,GPNE-I 是一种杂多糖,主要由葡聚糖结构域和 I 型和 II 型阿拉伯半乳聚糖(AG-I 和 AG-II)组成。GPNE-II 是一种由(1→4)-α-d-Glcp 主链组成的葡聚糖,每个两个残基的 O-6 位有取代。(1→3)-α-d-Glcp 和(1→6)-α-d-Glcp 位于支链上。在这两个片段中,都检测到了α-和β-t-Glcp 作为还原末端和→4)-α-Glcp 作为非还原末端。GPNE-I 和 GPNE-II 的支化度分别为 38.17%和 50.78%。免疫实验表明,GPNE-I 比 GPN 和 GPNE-II 更有效地刺激淋巴细胞增殖,表明前者具有作为免疫调节剂的应用潜力,表明 GPNE-I 可能是 GPN 促进淋巴细胞增殖的核心活性结构域和必要结构域。